Drugs Approved for Esophageal Cancer - National Cancer Institute

Drugs Approved for Esophageal Cancer - National Cancer Institute

Drugs Approved for Esophageal Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for esophageal cancer, including gastroesophageal junction cancer. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in esophageal cancer that are not listed here.

ON THIS PAGE

• Drugs Approved for Gastroesophageal Junction Cancer
• Drug Combinations Used in Esophageal Cancer

Drugs Approved for Gastroesophageal Junction Cancer

• Cyramza (Ramucirumab)
• Docetaxel
• Herceptin (Trastuzumab)
• Keytruda (Pembrolizumab)
• Lonsurf (Trifluridine and Tipiracil Hydrochloride)
• Pembrolizumab
• Ramucirumab
• Taxotere (Docetaxel)
• Trastuzumab
• Trifluridine and Tipiracil Hydrochloride

Drug Combinations Used in Esophageal Cancer

• FU-LV
• XELIRI

Related Resources

• Esophageal Cancer—Patient Version
• Chemotherapy and You: Support for People With Cancer

• Updated: May 1, 2019